CMV Preventive and Treatment Studies in Children Undergoing Haematopoietic Stem Cell Transplant: A Systematic Review
Cytomegalovirus (CMV) is one of the most important infectious causes of morbidity and mortality in children undergoing haematopoietic stem cell transplant (HSCT). However, the evidence for preventing and treating CMV disease in children in this context remains limited. We sought to review the current available evidence regarding the prevention and management of CMV infection and disease in children with HSCT and propose future research areas which could better inform evidence-based management.
Authors
- Lara Fusani
- L Galli
- Eleonora Fusco (ORCID: https://orcid.org/0000-0002-9629-2372)
- Seilesh Kadambari (ORCID: https://orcid.org/0000-0003-3658-7635)
- J. Breuer
- Alasdair Bamford
- Kanchan Rao
- Mariana Fonseca
Institutions
- Great Ormond Street Hospital (GB)
- Great Ormond Street Hospital for Children NHS Foundation Trust (GB)
- Meyer Children's Hospital (IT)
- Institute of Infection and Immunity (CA)
- University of Florence (IT)
- University College London (GB)
Publication Details
- Journal
- Reviews in Medical Virology
- Published
- 2026-02-18
- DOI
- https://doi.org/10.1002/rmv.70120
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00